Follow
Aron Park
Aron Park
Verified email at gachon.ac.kr
Title
Cited by
Cited by
Year
Zingerone suppresses tumor development through decreasing cyclin D1 expression and inducing mitotic arrest
JS Choi, J Ryu, WY Bae, A Park, S Nam, JE Kim, JW Jeong
International journal of molecular sciences 19 (9), 2832, 2018
372018
A deep learning model for cell growth inhibition IC50 prediction and its application for gastric cancer patients
M Joo, A Park, K Kim, WJ Son, HS Lee, GT Lim, J Lee, DH Lee, J An, ...
International journal of molecular sciences 20 (24), 6276, 2019
312019
A comprehensive evaluation of regression-based drug responsiveness prediction models, using cell viability inhibitory concentrations (IC50 values)
A Park, M Joo, K Kim, WJ Son, GT Lim, J Lee, JH Kim, DH Lee, S Nam
Bioinformatics 38 (10), 2810-2817, 2022
172022
Machine learning-derived gut microbiome signature predicts fatty liver disease in the presence of insulin resistance
BE Kang, A Park, H Yang, Y Jo, TG Oh, SM Jeong, Y Ji, HL Kim, HN Kim, ...
Scientific Reports 12 (1), 21842, 2022
72022
PATHOME-Drug: a subpathway-based polypharmacology drug-repositioning method
S Nam, S Lee, S Park, J Lee, A Park, YH Kim, T Park
Bioinformatics 38 (2), 444-452, 2022
72022
Deep learning for stage prediction in neuroblastoma using gene expression data
A Park, S Nam
Genomics & Informatics 17 (3), 2019
72019
A performance evaluation of drug response prediction models for individual drugs
A Park, Y Lee, S Nam
Scientific Reports 13 (1), 11911, 2023
42023
Plasma aldo-keto reductase family 1 member B10 as a biomarker performs well in the diagnosis of nonalcoholic steatohepatitis and fibrosis
A Park, SJ Choi, S Park, SM Kim, HE Lee, M Joo, KK Kim, D Kim, ...
International Journal of Molecular Sciences 23 (9), 5035, 2022
42022
miRDM-rfGA: Genetic algorithm-based identification of a miRNA set for detecting type 2 diabetes
A Park, S Nam
BMC Medical Genomics 16 (1), 195, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–9